Chaim Shustik

9.3k total citations · 1 hit paper
74 papers, 4.5k citations indexed

About

Chaim Shustik is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Chaim Shustik has authored 74 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 33 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Chaim Shustik's work include Multiple Myeloma Research and Treatments (32 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lymphoma Diagnosis and Treatment (17 papers). Chaim Shustik is often cited by papers focused on Multiple Myeloma Research and Treatments (32 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lymphoma Diagnosis and Treatment (17 papers). Chaim Shustik collaborates with scholars based in Canada, United States and Italy. Chaim Shustik's co-authors include Philip R. Greipp, Pieter Sonneveld, Heinz Ludwig, Brian G.M. Durie, Jan Westin, Kazuyuki Shimizu, J. A. Child, Jesús F. San Miguel, Gareth J. Morgan and Patrizia Tosi and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Chaim Shustik

73 papers receiving 4.3k citations

Hit Papers

International Staging System for Multiple Myeloma 2005 2026 2012 2019 2005 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaim Shustik Canada 29 2.5k 2.0k 1.9k 1.1k 1.0k 74 4.5k
Ulrich Jäger Austria 45 2.4k 0.9× 1.8k 0.9× 1.7k 0.9× 1.0k 1.0× 1.2k 1.2× 172 5.7k
Sung‐Soo Yoon South Korea 35 1.8k 0.7× 1.6k 0.8× 1.5k 0.8× 733 0.7× 637 0.6× 342 4.2k
Anna Marina Liberati Italy 31 1.3k 0.5× 1.1k 0.6× 1.9k 1.0× 1.3k 1.2× 689 0.7× 148 3.8k
Jordi Esteve Spain 43 4.9k 1.9× 2.6k 1.3× 1.8k 0.9× 1.2k 1.1× 1.8k 1.7× 262 7.6k
Giuseppe Avvisati Italy 43 5.0k 2.0× 4.1k 2.1× 1.5k 0.8× 512 0.5× 922 0.9× 202 7.5k
Johannes Drach Austria 46 3.2k 1.3× 3.4k 1.7× 3.2k 1.6× 1.7k 1.6× 1.4k 1.3× 177 7.4k
Jean‐François Rossi France 36 3.2k 1.3× 2.7k 1.4× 2.9k 1.5× 926 0.9× 693 0.7× 110 6.4k
Maria Teresa Voso Italy 39 2.7k 1.0× 2.4k 1.2× 1.1k 0.6× 763 0.7× 1.0k 1.0× 239 5.3k
Patrizia Tosi Italy 35 5.2k 2.1× 3.6k 1.8× 3.0k 1.6× 427 0.4× 1.0k 1.0× 146 6.6k
Mohamad A. Hussein United States 33 2.5k 1.0× 2.2k 1.1× 2.2k 1.1× 591 0.6× 916 0.9× 129 4.8k

Countries citing papers authored by Chaim Shustik

Since Specialization
Citations

This map shows the geographic impact of Chaim Shustik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaim Shustik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaim Shustik more than expected).

Fields of papers citing papers by Chaim Shustik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaim Shustik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaim Shustik. The network helps show where Chaim Shustik may publish in the future.

Co-authorship network of co-authors of Chaim Shustik

This figure shows the co-authorship network connecting the top 25 collaborators of Chaim Shustik. A scholar is included among the top collaborators of Chaim Shustik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaim Shustik. Chaim Shustik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chari, Ajai, Saulius Girnius, Saurabh Chhabra, et al.. (2017). Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 130. 3111–3111. 2 indexed citations
2.
Shustik, Chaim, Isabelle Bence‐Bruckler, Robert Delage, et al.. (2017). Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia. Annals of Hematology. 96(7). 1185–1196. 18 indexed citations
3.
Reece, Donna, Dan M. Sullivan, Sagar Lonial, et al.. (2010). Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma. Cancer Chemotherapy and Pharmacology. 67(1). 57–67. 94 indexed citations
4.
Wang, Béatrice, et al.. (2010). Composite Cutaneous Lymphoma in a Patient With Rheumatoid Arthritis Treated With Methotrexate. American Journal of Dermatopathology. 32(1). 65–70. 14 indexed citations
5.
Shustik, Chaim, Andrew R. Belch, Sue Robinson, et al.. (2006). A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7. British Journal of Haematology. 136(2). 203–211. 58 indexed citations
6.
Roberge, David, et al.. (2006). Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?. British Journal of Dermatology. 156(1). 57–61. 22 indexed citations
8.
Assouline, Sarit, Marie‐Pierre Sylvestre, Philippe Carrière, Chaim Shustik, & Pierre Laneuville. (2005). Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high‐dose cyclophosphamide: a retrospective review of 141 patients. Transfusion. 46(2). 174–179. 5 indexed citations
9.
Rhode, Barbara M., Chaim Shustik, Nicolas V. Christou, & Lloyd D. MacLean. (1999). Iron Absorption and Therapy after Gastric Bypass. Obesity Surgery. 9(1). 17–21. 84 indexed citations
11.
Kremer, Richard, et al.. (1996). Parathyroid-hormone-related peptide in hematologic malignancies. The American Journal of Medicine. 100(4). 406–411. 60 indexed citations
13.
Jensen, Gitte S., et al.. (1995). Circulating B-Ceils in Follicular Non-Hodgkin’s Lymphoma Show Variant Expression of L-Selectin Epitopes. Current topics in microbiology and immunology. 194. 171–177. 1 indexed citations
14.
Shustik, Chaim, Bruce M. Jamison, Carlo Alfieri, Sabine Scherer, & Rolf Loertscher. (1995). A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplantation. British Journal of Haematology. 91(1). 167–168. 16 indexed citations
15.
Browman, George P., Daniel E. Bergsagel, Séamus O’Reilly, et al.. (1995). Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.. Journal of Clinical Oncology. 13(9). 2354–2360. 76 indexed citations
16.
Newkirk, Marianna M., Jeffrey B. Shiroky, Newell W. Johnson, et al.. (1995). RHEUMATIC DISEASE PATIENTS, PRONE TO SJÖGREN'S SYNDROME AND/OR LYMPHOMA, MOUNT AN ANTIBODY RESPONSE TO BHRF1, THE EPSTEIN-BARR VIRAL HOMOLOGUE OF BCL-2. Lara D. Veeken. 35(11). 1075–1081. 22 indexed citations
17.
Brox, Alan & Chaim Shustik. (1993). Non-Hodgkin's Lymphoma of the Spleen. Leukemia & lymphoma. 11(3-4). 165–171. 36 indexed citations
18.
Gros, Piet & Chaim Shustik. (1991). Multidrug Resistance: A Novel Class of Membrane-Associated Transport Proteins is Identified. Cancer Investigation. 9(5). 563–569. 15 indexed citations
19.
Henderson, Janet E., Chaim Shustik, Richard Kremer, et al.. (1990). Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. Journal of Bone and Mineral Research. 5(2). 105–113. 115 indexed citations
20.
Yue, Rui, et al.. (1978). Studies into the occurrence of soluble antigen-antibody complexes in disease. VIII. Fractionation of rheumatoid samples containing immune complex-like material.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(3). 252–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026